FDA NDC Directory · JSON-LD · Markdown

IRBESARTAN

NDC 62332-042 · HUMAN PRESCRIPTION DRUG · TABLET

Labeler / ManufacturerAlembic Pharmaceuticals Inc.
Marketing categoryAbbreviated NDA (generic) · App ANDA091236
Dosage form / routeTABLET · ORAL
Active ingredientsIRBESARTAN (150 mg/1)
Marketing started20160701
Package count5

External sources

Source: openFDA. Public-domain (CC0).